Tag: Emblem S-ICD
Boston’s Empower leadless pacemaker demonstrates “excellent overall clinical performance” in MODULAR...
Boston Scientific recently announced late-breaking data from the MODULAR ATP clinical trial investigating the pacing performance of the company’s Empower leadless pacemaker. The data...
UNTOUCHED finds high conversion efficacy and low adverse event rate for...
The Emblem subcutaneous implantable defibrillator system (S-ICD; Boston Scientific) demonstrated a high conversion efficacy and low adverse event rate. Data from the UNTOUCHED trial...
Real-world data demonstrates success of SMART Pass on the S-ICD System
Results from an analysis of the LATITUDE database which evaluated the successful reduction of inappropriate shocks using the SMART Pass sensing filter in patients...
MADIT S-ICD global study enrols first patient to assess sudden cardiac...
Boston Scientific has initiated a worldwide study (MADIT S-ICD) that will evaluate the survival benefit of patients treated with the Emblem MRI Subcutaneous Implantable...